A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC ...
The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products ...
Delivery services often boast of their speed. For example, Federal Express is credited with the slogan, “When there is no tomorrow.” Yet speed shouldn’t eclipse safety—even if safety issues tend to be ...
A photo of a CanSino scientist holding a vial of its Ad5-based COVID-19 vaccine. CanSino Biologics began a clinical trial of its Ad5-based COVID-19 vaccine on March 16. Credit: CanSino Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results